Show simple item record

dc.contributor.authorThiemann, G.
dc.contributor.authorvan der Stelt, M.
dc.contributor.authorPetrosino, S.
dc.contributor.authorMolleman, A.
dc.contributor.authorDi Marzo, V.
dc.contributor.authorHasenoehrl, R.
dc.date.accessioned2009-07-27T13:48:24Z
dc.date.available2009-07-27T13:48:24Z
dc.date.issued2008
dc.identifier.citationThiemann , G , van der Stelt , M , Petrosino , S , Molleman , A , Di Marzo , V & Hasenoehrl , R 2008 , ' The role of the CB1 cannabinoid receptor and its endogenous ligands, anandamide and 2-arachidonoylglycerol, in amphetamine-induced behavioural sensitization ' , Behavioural Brain Research , vol. 187 , no. 2 , pp. 289-296 . https://doi.org/10.1016/j.bbr.2007.09.022
dc.identifier.issn0166-4328
dc.identifier.otherPURE: 124981
dc.identifier.otherPURE UUID: e7e95ece-5991-4fdb-aca4-ffe57b3e6d73
dc.identifier.otherdspace: 2299/3730
dc.identifier.otherScopus: 38049082534
dc.identifier.urihttp://hdl.handle.net/2299/3730
dc.descriptionOriginal article can be found at: http://www.sciencedirect.com/science/journal/01664328 Copyright Elsevier B. V. DOI: 10.1016/j.bbr.2007.09.022 [Full text of this article is not available in the UHRA]
dc.description.abstractCannabinoid receptors and their endogenous ligands (endocannabinoids) have been implicated in cocaine and amphetamine reward. Their role in psychostimulant-induced behavioural sensitization still has to be determined. The purpose of the present study was, for one, to compare the effects of a pharmacological and genetic manipulation of CB1 cannabinoid receptors on amphetamine-induced locomotor sensitization in mice, and, secondly, to quantify the concentration of anandamide and 2-arachidonoylglycerol in different forebrain areas of behaviourally sensitized animals. The results can be summarized as follows: CB1 knockout mice failed to sensitize to the locomotor stimulant effects of amphetamine. On the contrary, administration of the CB1 receptor antagonist SR141716A (rimonabant; 3 mg/kg; i.p.) increased amphetamine sensitization in wild-type animals, indicating that the difference between CB1 knockouts and SR141716A treated animals could be due to the ‘chronic’ versus ‘acute’ loss of CB1 receptor function, or, alternatively, that SR141716A could exert pharmacological effects beyond its proposed CB1 antagonistic action. Furthermore, sensitized wild-type mice and animals, which had received a single amphetamine injection on the challenge day, both had increased anandamide concentrations in the dorsal striatum and decreased anandamide levels in the ventral striatum, comprising nucleus accumbens. 2-Arachidonoylglycerol levels were decreased in the ventral striatum of sensitized animals only. Together, these findings suggest that prolonged activation of dopamine receptors could alter endocannabinoid levels and support the proposed involvement of the CB1 receptor in amphetamine sensitization.en
dc.language.isoeng
dc.relation.ispartofBehavioural Brain Research
dc.subjectBasal ganglia
dc.subjecthippocampus
dc.subjectRimonabant
dc.subjectpsychostimulant
dc.titleThe role of the CB1 cannabinoid receptor and its endogenous ligands, anandamide and 2-arachidonoylglycerol, in amphetamine-induced behavioural sensitizationen
dc.contributor.institutionDepartment of Human and Environmental Sciences
dc.description.statusPeer reviewed
dcterms.dateAccepted2008
rioxxterms.versionofrecordhttps://doi.org/10.1016/j.bbr.2007.09.022
rioxxterms.typeJournal Article/Review
herts.preservation.rarelyaccessedtrue


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record